Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA1c and fasting plasma glucose
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0275
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA1c and fasting plasma glucose ; volume:14 ; number:1 ; day:28 ; month:3 ; year:2017 ; pages:1-9 ; date:12.2017
Clinical proteomics ; 14, Heft 1 (28.3.2017), 1-9, 12.2017
- Schlagwort
-
Endokrinologie
- Urheber
-
Spiller, Sandro
- Beteiligte Personen und Organisationen
-
Li, Yichao
Blüher, Matthias
Welch, Lonnie
Hoffmann, Ralf
SpringerLink (Online service)
- DOI
-
10.1186/s12014-017-9145-1
- URN
-
urn:nbn:de:1111-2017041512498
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spiller, Sandro
- Li, Yichao
- Blüher, Matthias
- Welch, Lonnie
- Hoffmann, Ralf
- SpringerLink (Online service)
Ähnliche Objekte (12)
HbA1c : glycated hemoglobin and diabetes mellitus
Causal Effect of Higher Glycated Hemoglobin (HbA1c) Levels on Knee Osteoarthritis Risk: A Mendelian Randomization Study
Association between glycated hemoglobin (HbA1c) level and cardiac perfusion and function on gated myocardial perfusion SPECT
Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
Immunochemical Determination of Hemoglobin-A1c Utilizing a Glycated Peptide as Hemoglobin-A1c Analogon
Method comparison of Particle Enhanced Immunoturbidimetry (PEIT) with High Performance Liquid Chromatography (HPLC) for glycated hemoglobin (HbA1c) analysis
Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Editorial: Adipose tissue dysfunction
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
HbA1c : glycated hemoglobin and diabetes mellitus
Causal Effect of Higher Glycated Hemoglobin (HbA1c) Levels on Knee Osteoarthritis Risk: A Mendelian Randomization Study
Association between glycated hemoglobin (HbA1c) level and cardiac perfusion and function on gated myocardial perfusion SPECT
Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
Immunochemical Determination of Hemoglobin-A1c Utilizing a Glycated Peptide as Hemoglobin-A1c Analogon
Method comparison of Particle Enhanced Immunoturbidimetry (PEIT) with High Performance Liquid Chromatography (HPLC) for glycated hemoglobin (HbA1c) analysis
Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Editorial: Adipose tissue dysfunction
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
HbA1c : glycated hemoglobin and diabetes mellitus
Causal Effect of Higher Glycated Hemoglobin (HbA1c) Levels on Knee Osteoarthritis Risk: A Mendelian Randomization Study
Association between glycated hemoglobin (HbA1c) level and cardiac perfusion and function on gated myocardial perfusion SPECT
Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
Immunochemical Determination of Hemoglobin-A1c Utilizing a Glycated Peptide as Hemoglobin-A1c Analogon
Method comparison of Particle Enhanced Immunoturbidimetry (PEIT) with High Performance Liquid Chromatography (HPLC) for glycated hemoglobin (HbA1c) analysis
Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Editorial: Adipose tissue dysfunction
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control